Lonza Group Ltd (LZAGY)
57.59
+0.95
(+1.68%)
USD |
OTCM |
May 03, 15:46
Lonza Group Price: 57.59 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 02, 2024 | 56.81 | 56.81 | 56.02 | 56.64 | 21149.00 |
May 01, 2024 | 55.38 | 56.08 | 54.81 | 55.13 | 16097.00 |
Apr 30, 2024 | 55.80 | 56.12 | 55.33 | 55.33 | 66412.00 |
Apr 29, 2024 | 57.35 | 57.44 | 57.16 | 57.27 | 38611.00 |
Apr 26, 2024 | 57.36 | 57.81 | 57.36 | 57.79 | 33920.00 |
Apr 25, 2024 | 55.92 | 56.62 | 55.86 | 56.50 | 22539.00 |
Apr 24, 2024 | 57.57 | 57.68 | 56.93 | 57.27 | 59385.00 |
Apr 23, 2024 | 57.69 | 58.06 | 57.57 | 57.57 | 92750.00 |
Apr 22, 2024 | 55.84 | 55.95 | 55.48 | 55.69 | 28853.00 |
Apr 19, 2024 | 55.35 | 55.41 | 54.95 | 55.15 | 49184.00 |
Apr 18, 2024 | 55.73 | 56.34 | 55.56 | 55.65 | 32374.00 |
Apr 17, 2024 | 57.37 | 57.45 | 56.97 | 57.30 | 33059.00 |
Apr 16, 2024 | 57.54 | 57.89 | 57.39 | 57.64 | 36082.00 |
Apr 15, 2024 | 58.75 | 58.81 | 57.97 | 58.05 | 27028.00 |
Apr 12, 2024 | 58.69 | 58.71 | 58.17 | 58.26 | 41461.00 |
Apr 11, 2024 | 59.73 | 59.79 | 59.07 | 59.54 | 26009.00 |
Apr 10, 2024 | 58.42 | 59.06 | 58.26 | 58.68 | 100742.0 |
Apr 09, 2024 | 60.50 | 60.62 | 60.07 | 60.54 | 234957.0 |
Apr 08, 2024 | 61.46 | 61.60 | 61.18 | 61.48 | 21874.00 |
Apr 05, 2024 | 60.27 | 60.79 | 60.27 | 60.59 | 32104.00 |
Apr 04, 2024 | 60.90 | 61.17 | 59.93 | 59.99 | 45532.00 |
Apr 03, 2024 | 59.68 | 60.42 | 59.63 | 60.03 | 46167.00 |
Apr 02, 2024 | 58.94 | 58.94 | 58.37 | 58.72 | 646455.0 |
Apr 01, 2024 | 62.87 | 62.87 | 59.77 | 60.06 | 41283.00 |
Mar 28, 2024 | 60.10 | 60.12 | 59.67 | 59.91 | 462718.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
30.27
Minimum
May 13 2019
85.40
Maximum
Aug 27 2021
55.29
Average
57.33
Median
Price Benchmarks
Roche Holding AG | 29.84 |
AC Immune SA | 2.39 |
CRISPR Therapeutics AG | 55.88 |
Addex Therapeutics Ltd | 8.60 |
NLS Pharmaceutics Ltd | 0.1323 |
Price Related Metrics
PE Ratio | 57.98 |
PS Ratio | 5.635 |
Price to Book Value | 3.691 |
Earnings Yield | 1.72% |
Market Cap | 41.53B |
Operating PE Ratio | 43.50 |
Normalized PE Ratio | 57.76 |